A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive ...
During a live event, Carol Ann Huff, MD, and participants discussed real-world evidence and personal experiences with talquetamab in relapsed/refractory multiple myeloma.
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...